California's Prop 71 Divides Debate on Stem Cells
By Women's e-News,
Women's e-News
| 10. 26. 2004
An alliance of pro-choice activists in California is splitting with usual allies to oppose a popular stem-cell research proposition. The group says the initiative does not adequately protect poor women from becoming a biological marketplace.
SAN FRANCISCO (WOMENSENEWS)--As though to prove the adage that politics makes strange bedfellows, some pro-choice activists and feminists are joining anti-choice activists and the Catholic Church in opposing a controversial $3 billion stem-cell research initiative on California's November ballot.
The Pro-Choice Alliance Against Prop 71 says that while it generally supports embryonic stem-cell research it cannot support this specific initiative.
President George W. Bush restricted federal funds for embryonic stem cell research to 78 stem cell lines in 2001, and only 19 of those lines are available to researchers today. Prop 71 would defy the Bush administration by providing critical state funding for embryonic stem cell research.
The group argues that while millions of low-income Californian women lack basic health care, Prop 71 could relax safeguards over important ethical issues, such as the buying and selling of their embryos, and be a taxpayer-funded giveaway to...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...